216 related articles for article (PubMed ID: 38605171)
1. Robust and replicable functional brain signatures of 22q11.2 deletion syndrome and associated psychosis: a deep neural network-based multi-cohort study.
Supekar K; de Los Angeles C; Ryali S; Kushan L; Schleifer C; Repetto G; Crossley NA; Simon T; Bearden CE; Menon V
Mol Psychiatry; 2024 Apr; ():. PubMed ID: 38605171
[TBL] [Abstract][Full Text] [Related]
2. Neuroanatomical underpinnings of autism symptomatology in carriers and non-carriers of the 22q11.2 microdeletion.
Gudbrandsen M; Bletsch A; Mann C; Daly E; Murphy CM; Stoencheva V; Blackmore CE; Rogdaki M; Kushan L; Bearden CE; Murphy DGM; Craig MC; Ecker C
Mol Autism; 2020 Jun; 11(1):46. PubMed ID: 32513259
[TBL] [Abstract][Full Text] [Related]
3. Deep psychophysiological phenotyping of adolescents and adults with 22q11.2 deletion syndrome: a multilevel approach to defining core disease processes.
Parker DA; Cubells JF; Imes SL; Ruban GA; Henshey BT; Massa NM; Walker EF; Duncan EJ; Ousley OY
BMC Psychiatry; 2023 Jun; 23(1):425. PubMed ID: 37312091
[TBL] [Abstract][Full Text] [Related]
4. Attention Deficit Hyperactivity Disorder Symptoms and Psychosis in 22q11.2 Deletion Syndrome.
Niarchou M; Calkins ME; Moore TM; Tang SX; McDonald-McGinn DM; Zackai EH; Emanuel BS; Gur RC; Gur RE
Schizophr Bull; 2018 Jun; 44(4):824-833. PubMed ID: 29040797
[TBL] [Abstract][Full Text] [Related]
5. Sleep EEG in young people with 22q11.2 deletion syndrome: A cross-sectional study of slow-waves, spindles and correlations with memory and neurodevelopmental symptoms.
Donnelly NA; Bartsch U; Moulding HA; Eaton C; Marston H; Hall JH; Hall J; Owen MJ; van den Bree MBM; Jones MW
Elife; 2022 Aug; 11():. PubMed ID: 36039635
[TBL] [Abstract][Full Text] [Related]
6. Functional Dysconnectivity in Ventral Striatocortical Systems in 22q11.2 Deletion Syndrome.
Tepper Á; Cuiza A; Alliende LM; Mena C; Ramirez-Mahaluf JP; Iruretagoyena B; Ornstein C; Fritsch R; Nachar R; González-Valderrama A; Undurraga J; Cruz JP; Tejos C; Fornito A; Repetto G; Crossley N
Schizophr Bull; 2022 Mar; 48(2):485-494. PubMed ID: 34931688
[TBL] [Abstract][Full Text] [Related]
7. Stimulant treatment effectiveness, safety and risk for psychosis in individuals with 22q11.2 deletion syndrome.
Basel D; Mosheva M; Maeder J; Schneider M; Shani S; Weinberger R; Eliez S; Gothelf D
Eur Child Adolesc Psychiatry; 2022 Sep; 31(9):1367-1375. PubMed ID: 33871687
[TBL] [Abstract][Full Text] [Related]
8. Blood brain barrier permeability increases with age in individuals with 22q11.2 deletion syndrome.
Taler M; Mekori-Domachevsky E; Vergaelen E; Claes S; Serur Y; Dar S; Levy-Shraga Y; Weizman A; Swillen A; Gothelf D
World J Biol Psychiatry; 2022 Jul; 23(6):475-482. PubMed ID: 34854358
[TBL] [Abstract][Full Text] [Related]
9. White matter microstructural abnormalities of the cingulum bundle in youths with 22q11.2 deletion syndrome: associations with medication, neuropsychological function, and prodromal symptoms of psychosis.
Kates WR; Olszewski AK; Gnirke MH; Kikinis Z; Nelson J; Antshel KM; Fremont W; Radoeva PD; Middleton FA; Shenton ME; Coman IL
Schizophr Res; 2015 Jan; 161(1):76-84. PubMed ID: 25066496
[TBL] [Abstract][Full Text] [Related]
10. Association between early-onset Parkinson disease and 22q11.2 deletion syndrome: identification of a novel genetic form of Parkinson disease and its clinical implications.
Butcher NJ; Kiehl TR; Hazrati LN; Chow EW; Rogaeva E; Lang AE; Bassett AS
JAMA Neurol; 2013 Nov; 70(11):1359-66. PubMed ID: 24018986
[TBL] [Abstract][Full Text] [Related]
11. Negative subthreshold psychotic symptoms distinguish 22q11.2 deletion syndrome from other neurodevelopmental disorders: A two-site study.
Mekori-Domachevsky E; Guri Y; Yi J; Weisman O; Calkins ME; Tang SX; Gross R; McDonald-McGinn DM; Emanuel BS; Zackai EH; Zalsman G; Weizman A; Gur RC; Gur RE; Gothelf D
Schizophr Res; 2017 Oct; 188():42-49. PubMed ID: 28041919
[TBL] [Abstract][Full Text] [Related]
12. The social brain network in 22q11.2 deletion syndrome: a diffusion tensor imaging study.
Olszewski AK; Kikinis Z; Gonzalez CS; Coman IL; Makris N; Gong X; Rathi Y; Zhu A; Antshel KM; Fremont W; Kubicki MR; Bouix S; Shenton ME; Kates WR
Behav Brain Funct; 2017 Feb; 13(1):4. PubMed ID: 28209179
[TBL] [Abstract][Full Text] [Related]
13. Altered functional brain dynamics in chromosome 22q11.2 deletion syndrome during facial affect processing.
Cornblath EJ; Mahadevan A; He X; Ruparel K; Lydon-Staley DM; Moore TM; Gur RC; Zackai EH; Emanuel B; McDonald-McGinn DM; Wolf DH; Satterthwaite TD; Roalf DR; Gur RE; Bassett DS
Mol Psychiatry; 2022 Feb; 27(2):1158-1166. PubMed ID: 34686764
[TBL] [Abstract][Full Text] [Related]
14. Patterns of Cortical Folding Associated with Autistic Symptoms in Carriers and Noncarriers of the 22q11.2 Microdeletion.
Gudbrandsen M; Mann C; Bletsch A; Daly E; Murphy CM; Stoencheva V; Blackmore CE; Rogdaki M; Kushan L; Bearden CE; Murphy DGM; Craig MC; Ecker C
Cereb Cortex; 2020 Sep; 30(10):5281-5292. PubMed ID: 32420595
[TBL] [Abstract][Full Text] [Related]
15. Shyness discriminates between children with 22q11.2 deletion syndrome and Williams syndrome and predicts emergence of psychosis in 22q11.2 deletion syndrome.
Schonherz Y; Davidov M; Knafo A; Zilkha H; Shoval G; Zalsman G; Frisch A; Weizman A; Gothelf D
J Neurodev Disord; 2014 Feb; 6(1):3. PubMed ID: 24517288
[TBL] [Abstract][Full Text] [Related]
16. Social cognition and real-life functioning in patient samples with 22q11.2 deletion syndrome with or without psychosis, compared to a large sample of patients with schizophrenia only and healthy controls.
Frascarelli M; Accinni T; Buzzanca A; Carlone L; Ghezzi F; Moschillo A; Kotzalidis GD; Bucci P; Giordano GM; Fanella M; Di Bonaventura C; Putotto C; Marino B; Pasquini M; Biondi M; Di Fabio F
J Neuropsychol; 2023 Sep; 17(3):564-583. PubMed ID: 37159847
[TBL] [Abstract][Full Text] [Related]
17. Amygdala subdivisions exhibit aberrant whole-brain functional connectivity in relation to stress intolerance and psychotic symptoms in 22q11.2DS.
Delavari F; Rafi H; Sandini C; Murray RJ; Latrèche C; Van De Ville D; Eliez S
Transl Psychiatry; 2023 May; 13(1):145. PubMed ID: 37142582
[TBL] [Abstract][Full Text] [Related]
18. Elevated Proinflammatory Markers in 22q11.2 Deletion Syndrome Are Associated With Psychosis and Cognitive Deficits.
Mekori-Domachevsky E; Taler M; Shoenfeld Y; Gurevich M; Sonis P; Weisman O; Weizman A; Gothelf D
J Clin Psychiatry; 2017; 78(9):e1219-e1225. PubMed ID: 29141125
[TBL] [Abstract][Full Text] [Related]
19. The Neuroanatomy of Autism Spectrum Disorder Symptomatology in 22q11.2 Deletion Syndrome.
Gudbrandsen M; Daly E; Murphy CM; Wichers RH; Stoencheva V; Perry E; Andrews D; Blackmore CE; Rogdaki M; Kushan L; Bearden CE; Murphy DGM; Craig MC; Ecker C
Cereb Cortex; 2019 Jul; 29(8):3655-3665. PubMed ID: 30272146
[TBL] [Abstract][Full Text] [Related]
20. Identifying neurodevelopmental anomalies of white matter microstructure associated with high risk for psychosis in 22q11.2DS.
Bagautdinova J; Padula MC; Zöller D; Sandini C; Schneider M; Schaer M; Eliez S
Transl Psychiatry; 2020 Nov; 10(1):408. PubMed ID: 33235187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
